Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490484 | PMC |
| http://dx.doi.org/10.1371/annotation/81e8574c-71c3-4a76-b1aa-e3c7b058af69 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Improving quality of life through hyaluronic acid-based fillers after orbital cancer treatment.
Front Oncol
December 2024
Department of Pediatrics, Sapienza University, Rome, Italy.
Background: Myoepithelial carcinoma is a very rare yet aggressive tumor in children. Surgical intervention and local radiotherapy often lead to post-therapy complications, affecting both the aesthetic and functional quality of life in survivors. Hyaluronic acid (HA) dermal fillers offer a minimally invasive option to improve the appearance and quality of life for these patients once they are declared tumor-free.
View Article and Find Full Text PDFAssessing institutional responsibility in scientific misconduct: A case study of enoximone research by Joachim Boldt.
Clin Trials
December 2024
Institute of General Practice and Public Health, Claudiana-College of Health Professions, Bolzano, Italy.
Background: Enoximone, a phosphodiesterase III inhibitor, was approved in Germany in 1989 and initially proposed for heart failure and perioperative cardiac conditions. The research of Joachim Boldt and his supervisor Gunter Hempelmann came under scrutiny after investigations revealed systematic scientific misconduct leading to numerous retractions. Therefore, early enoximone studies by Boldt and Hempelmann from 1988 to 1991 were reviewed.
View Article and Find Full Text PDFRecord-low Antarctic sea ice in 2023 increased ocean heat loss and storms.
Nature
December 2024
National Oceanography Centre, Southampton, UK.
Recent Antarctic sea-ice decline is a substantial source of concern, notably the record low in 2023 (ref. ). Progress has been made towards establishing the causes of ice loss but uncertainty remains about its consequences for ocean-atmosphere interaction.
View Article and Find Full Text PDFTwo Moroccan Families with Emery-Dreifuss Muscular Dystrophy and Report of a Novel Pathogenic Variant.
Mol Syndromol
December 2024
Research team in genomics and molecular epidemiology of genetic diseases, Genomics Center of Human Pathologies, Faculty of Medicine and Pharmacy, University Mohammed V of Rabat, Rabat, Morocco.
Article Synopsis
- - Emery-Dreifuss muscular dystrophy (EDMD) is a neuromuscular disorder that leads to muscle weakness and heart problems, mainly caused by mutations in specific genes, identified through next-generation sequencing (NGS).
- - The study examined two Moroccan patients with EDMD, revealing one with a known splicing variant and another with a new frameshift variant, along with testing relatives for carrier status.
- - The findings highlight NGS as crucial for accurately diagnosing EDMD, managing patient care, and providing genetic counseling to affected families.
An inborn error of metabolism presenting with apparently isolated subacute neuropsychiatric symptoms in an adolescent.
Ther Adv Rare Dis
November 2024
Department of Pediatrics, University of Alabama at Birmingham, 314 Children's Harbor Building, 1600 7th Avenue South, Birmingham, AL 35233, USA.
We discuss a previously healthy adolescent male presenting with subacute neuropsychiatric issues, tremors, hyperreflexia, and hypertension. Laboratory studies revealed acute on chronic kidney disease. Additional investigations yielded a treatable late-onset inborn error of metabolism (IEM).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!